Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. West Pharmaceutical Services, Inc shares valued at $218,211 were sold by Witherspoon Charles on Oct 29 ’24. At $310.40 per share, Witherspoon Charles sold 703 shares. The insider’s holdings dropped to 1,253 shares worth approximately $0.26 million following the completion of this transaction.
Also, Witherspoon Charles sold 1,029 shares, netting a total of over 308,700 in proceeds. Following the sale of shares at $300.00 each, the insider now holds 1,478 shares.
Before that, Hofmann Thomas W had sold 617 shares from its account. In a trade valued at $225,773, the Director traded West Pharmaceutical Services, Inc shares for $365.92 each. Upon closing the transaction, the insider’s holdings decreased to 617 shares, worth approximately $9.17 million.
As published in their initiating research note from Evercore ISI on March 18, 2025, West Pharmaceutical Services, Inc [WST] has been an Outperform and the price target has been revised to $275. Analysts at Deutsche Bank upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in mid February. As of January 08, 2025, Citigroup has initiated its “Buy” rating for WST. Earlier on December 13, 2024, Wolfe Research initiated its rating. Their recommendation was “a Peer perform” for WST stock.
Analyzing WST Stock Performance
During the last five days, there has been a surge of approximately 0.70%. Over the course of the year, West Pharmaceutical Services, Inc shares have dropped approximately -35.71%. Shares of the company reached a 52-week high of $348.90 on 01/28/25 and a 52-week low of $187.43 on 04/09/25. A 50-day SMA is recorded $220.62, while a 200-day SMA reached $291.14.
Support And Resistance Levels for West Pharmaceutical Services, Inc (WST)
According to the 24-hour chart, there is a support level at 200.56, which, if violated, would cause prices to drop to 190.54. In the upper region, resistance lies at 219.94. The next price resistance is at 229.30. RSI (Relative Strength Index) is 45.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 7.56, which suggests the price will increase in the coming days. Percent R is at 35.05%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
